Lancet Infectious Diseases Review Examines Progress On Dengue Vaccine “The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue,” write the authors of a Lancet Infectious Diseases…
During a recent interview with The Hill’s “Blog Briefing Room,” Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, praised former President George W. Bush for the enactment of PEPFAR and commended the Obama administration’s commitment to global health issues for “being very open minded [and] saying we don’t have to go back and reinvent the wheel.”
As HIV Vaccine Conference Opens, Experts Appeal For Sustained Commitment To Global Fight Against Disease
Experts gathered for the start of a four-day conference on HIV vaccines in Paris called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.
Blog, Editorial Address Unsafe Abortion In Developing Countries In light of a recent Guttmacher Institute report that indicated 70,000 women in developing countries die each year from unsafe abortion, a Lancet editorial outlines ways to reduce deaths, and says, “The current political climate is favourable, because the global-gag rule (the…
HHS recently announced the FDA’s 100th approval of an antiretroviral drug for PEPFAR, PharmTech.com reports. Seventy-one of the more than 100 drugs reviewed by FDA for PEPFAR were generic products. HHS Secretary Kathleen Sebelius said in a statement, “This milestone exemplifies the dedication, caring, and hard work of all who strive to better the lives of those infected with or affected by HIV/AIDS” (10/15).
Rights Advocacy Not The Best Approach For Global Health “[T]he global campaign to equalise access to healthcare has had a surprising result: it has made global healthcare more unequal,” William Easterly, aÂ professor of economics at New York University and co-director of its Development Research Institute, writes in a Financial Times…
VOA News examines how the recession will be a factor in U.S. funding decisions about PEPFAR and other global health initiatives. According to VOA, the Obama administration’s proposed funding for HIV, tuberculosis and malaria in 2010 is “higher than the current fiscal year. However, the proposed increase is lower than in some years past.”
Tuberculosis deserves an effort as “substantial” as the one mounted against swine flu “to develop a new vaccine,” David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece. “Since April, … nearly one million men, women and children have died from TB, compared to 4,200 who have died from H1N1 flu globally. Why didn’t you see any headlines? Because 98 percent of the nearly two million people who die each year from TB live in the developing world, in places like Kenya … Yet TB continues to be a problem in [the U.S.] as well because in an age of globalization, germs cross borders without a passport,” McMurray writes.
Also In Global Health News: U.S. Aid To Somalia; Nigerian Health Workers Strike; Male Circumcision In Swaziland; PEPFAR In Uganda
U.S. Government Adjusts Aid Terms To Groups Seeking Humanitarian Grants In Somalia The U.S. State and Treasury departments together with USAID have reached an agreement that will allow several aid agencies in Somalia to receive humanitarian grants upon meeting several conditions, “unlock[ing] millions of dollars in relief resources that had…
The BBC examines the balance between funding for HIV/AIDS and for the broader health system and other diseases in Uganda.